BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35579526)

  • 1. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
    Aitken M; Chan MV; Urzua Fresno C; Farrell A; Islam N; McInnes MDF; Iwanochko M; Balter M; Moayedi Y; Thavendiranathan P; Metser U; Veit-Haibach P; Hanneman K
    Radiology; 2022 Sep; 304(3):566-579. PubMed ID: 35579526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
    Aitken M; Davidson M; Chan MV; Urzua Fresno C; Vasquez LI; Huo YR; McAllister BJ; Broncano J; Thavendiranathan P; McInnes MDF; Iwanochko MR; Balter M; Moayedi Y; Farrell A; Hanneman K
    Radiology; 2023 Apr; 307(2):e222483. PubMed ID: 36809215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
    J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.
    Tang R; Wang JT; Wang L; Le K; Huang Y; Hickey AJ; Emmett L
    Clin Nucl Med; 2016 Jul; 41(7):e327-39. PubMed ID: 26646995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial spin labeling (ASL-MRI) versus fluorodeoxyglucose-PET (FDG-PET) in diagnosing dementia: a systematic review and meta-analysis.
    Haidar H; Majzoub RE; Hajeer S; Abbas LA
    BMC Neurol; 2023 Oct; 23(1):385. PubMed ID: 37875879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.
    Youssef G; Leung E; Mylonas I; Nery P; Williams K; Wisenberg G; Gulenchyn KY; Dekemp RA; Dasilva J; Birnie D; Wells GA; Beanlands RS
    J Nucl Med; 2012 Feb; 53(2):241-8. PubMed ID: 22228794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
    Hanneman K; Kadoch M; Guo HH; Jamali M; Quon A; Iagaru A; Herfkens R
    Clin Nucl Med; 2017 Jul; 42(7):e328-e334. PubMed ID: 28418949
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mirshahvalad SA; Metser U; Basso Dias A; Ortega C; Yeung J; Veit-Haibach P
    Radiology; 2023 Apr; 307(2):e221598. PubMed ID: 36692397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
    Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
    J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
    Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
    Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect comparison of the diagnostic performance of
    Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J
    BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
    Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis.
    Divakaran S; Stewart GC; Lakdawala NK; Padera RF; Zhou W; Desai AS; Givertz MM; Mehra MR; Kwong RY; Hedgire SS; Ghoshhajra BB; Taqueti VR; Skali H; Dorbala S; Blankstein R; Di Carli MF
    Circ Cardiovasc Imaging; 2019 Jun; 12(6):e008975. PubMed ID: 31177817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
    Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Performance of Whole-Body MRI and FDG PET/CT in Evaluation of Multiple Myeloma Treatment Response: Systematic Review and Meta-Analysis.
    Rama S; Suh CH; Kim KW; Durieux JC; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 Apr; 218(4):602-613. PubMed ID: 34704461
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis.
    Kim K; Kim SJ
    Leuk Res; 2020 Dec; 99():106475. PubMed ID: 33189988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.